Novartis Expands BeiGene Tie-Up To TIGIT Inhibitor In $1bn-Plus Option Deal

 
• By Brian Yang
  
NOVARTIS EXPANDS COLLABORATION WITH BEIGENE TO TIGIT ANTIBODY IN NEW DEAL • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business